Ergoteles’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ergoteles’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,800	Closed	-$178K	–	1439
2021 Q2	$178K	Sell	13,800 -7,800	-36%	-$89.3K	﹤0.01%	1314
2021 Q1	$241K	Buy	+21,600	New	+$228K	0.01%	607
2020 Q4	–	Sell	-12,400	Closed	-$112K	–	790
2020 Q3	$112K	Buy	+12,400	New	+$123K	0.01%	531

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ergoteles's IRWD Position: Q3 2021 in Review

Ergoteles sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2021, closing a stake of 13,800 shares — an estimated $178K sold.

Ergoteles first reported a position in IRWD in Q3 2020 and held it in 3 quarters. The position peaked at $241K in Q1 2021. 227 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

Ergoteles reported no remaining Ironwood Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 13,800 Ironwood Pharmaceuticals shares in Q3 2021, an estimated $178K.
Ergoteles first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 3 quarters.
Ergoteles's Ironwood Pharmaceuticals position peaked at $241K in Q1 2021.
227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.